Chromocell Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
0.660
+0.029 (4.60%)
At close: Nov 22, 2024, 4:00 PM
0.625
-0.035 (-5.29%)
After-hours: Nov 22, 2024, 5:54 PM EST
Chromocell Therapeutics Employees
As of December 31, 2023, Chromocell Therapeutics had 8 total employees, including 4 full-time and 4 part-time employees. The number of employees increased by 6 or 300.00% compared to the previous year.
Employees
8
Change (1Y)
6
Growth (1Y)
300.00%
Revenue / Employee
n/a
Profits / Employee
-$1,258,470
Market Cap
3.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8 | 6 | 300.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| China Pharma Holdings | 231 |
| Genetic Technologies | 55 |
| Hepion Pharmaceuticals | 22 |
| Sonoma Pharmaceuticals | 10 |
| TNF Pharmaceuticals | 6 |
| Artelo Biosciences | 6 |
| Aptorum Group | 3 |
| Tharimmune | 3 |
CHRO News
- 1 day ago - Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates - GlobeNewsWire
- 24 days ago - Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain - GlobeNewsWire
- 4 weeks ago - Chromocell Announces Amendment to Stock Repurchase Plan - GlobeNewsWire
- 2 months ago - Chromocell to Participate in Life Sciences Investor Forum September 19th - GlobeNewsWire
- 3 months ago - Chromocell Announces Stock Repurchase Plan - GlobeNewsWire
- 4 months ago - Chromocell to Participate in the Virtual Investor Lunch Break Series - GlobeNewsWire
- 6 months ago - Chromocell To Present at Alliance Global Partner's Healthcare Company Showcase on Tuesday, May 21, 2024 - GlobeNewsWire
- 8 months ago - Chromocell Issues Letter to Stockholders from Chief Executive Officer - GlobeNewsWire